The global exosome research products market size was US$ 144.4 million in 2021. The global exosome research products market size is forecast to reach US$ 1156.4 million by 2030, growing at a compound annual growth rate (CAGR) of 26% during the forecast period from 2022 to 2030.
Exosomes, which are the smallest EVs, are particularly important in tumor microenvironments (TMEs). In addition, they promote angiogenesis, tumor metastasis, and immunosuppression. Additionally, there are three main categories of EVs based on size, biogenesis, and function. Different cell types secrete exosomes. Further, all body fluids contain them, including plasma, urine, serum, and saliva. These are mostly protein charges and RNA. Various cell lines produce exosomes, such as primary cultures, tumor cells, and virus-infected cells.
Factors Influencing Market Growth
Impact Analysis of COVID-19
Governments and pharmaceutical companies around the globe are working together to solve the challenges posed by the COVID-19 outbreak, from developing vaccines to organizing the supply chain for medicines. There are currently 115 vaccine candidates and 155 molecules in the R&D pipeline. In addition, commonly used drugs such as hydroxychloroquine have seen dramatic increases in demand for the treatment of COVID-19. The high demand for these drugs has created an opportunity for manufacturers of COVID-19 management drugs since many developed countries are short of these medications. Due to the demand for vaccines and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry will see significant growth in the future. Thus, COVID -19 significantly impacts the global exosome research products market.
Regional Insights
North America accounts for the largest market share for exosome research products. North America is the largest regional market for exosome research products. Several factors contribute to the growth of this market, such as government funding for life sciences research, a favorable regulatory environment, widespread interest in using exosomes, and excellent infrastructure for clinical and laboratory research. A number of national institutes support biotechnology and life science research in North America. Growing biotechnology, pharmaceutical industries, and an increase in cancer cases in the region also help support the market's growth.
Leading Competitors
The leading prominent companies profiled in the global exosome research products market are:
Scope of the Report
The global exosome research products market segmentation focuses on Product & Service, Application, End-User, and Region.
Segmentation based on Product & Service
Segmentation based on Application
Segmentation based on End-User
Segmentation based on Region
Table of Content
1 INTRODUCTION
1.1 MARKET DEFINITION
1.2 MARKET SEGMENTATION
1.3 RESEARCH TIMELINES
1.4 ASSUMPTIONS
1.5 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 DATA MINING
2.2 SECONDARY RESEARCH
2.3 PRIMARY RESEARCH
2.4 SUBJECT MATTER EXPERT ADVICE
2.5 QUALITY CHECK
2.6 FINAL REVIEW
2.7 DATA TRIANGULATION
2.8 BOTTOM-UP APPROACH
2.9 TOP-DOWN APPROACH
2.10 RESEARCH FLOW
3 EXECUTIVE SUMMARY
3.1 MARKET OVERVIEW
3.2 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
3.3 GLOBAL RECYCLED CARBON FIBER MARKET, BY PRODUCT & TYPE
3.4 GLOBAL RECYCLED CARBON FIBER MARKET, BY APPLICATION
3.5 GLOBAL RECYCLED CARBON FIBER MARKET, BY END-USER
3.6 FUTURE MARKET OPPORTUNITIES
3.7 GLOBAL MARKET SPLIT
4 MARKET OUTLOOK
4.1 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET OUTLOOK
4.2 MARKET DRIVERS
4.3 MARKET RESTRAINTS
4.4 MARKET OPPORTUNITIES
4.5 IMPACT OF COVID – 19 ON EXOSOME RESEARCH PRODUCTS MARKET
5 MARKET, BY PRODUCT & TYPE
5.1 OVERVIEW
5.2 INSTRUMENTS
5.3 SERVICES
5.4 KITS & REAGENTS
6 MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 Cancer Applications
6.2.1 Breast Cancer
6.2.2 Prostate Cancer
6.2.3 Lung Cancer
6.2.4 Colorectal Cancer
6.3 Non-cancer Applications
7 MARKET, BY END-USER
7.1 OVERVIEW
7.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
7.3 HOSPITALS & CLINICAL TESTING LABORATORIES
7.4 ACADEMIC & RESEARCH INSTITUTES
8 MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 Western Europe
8.3.2.1The UK
8.3.2.2Germany
8.3.2.3France
8.3.2.4Italy
8.3.2.5Spain
8.3.2.6Rest of Western Europe
8.3.3Eastern Europe
8.3.3.1Poland
8.3.3.2Russia
8.3.3.3Rest of Eastern Europe
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 Australia & New Zealand
8.4.6 ASEAN
8.4.7 Rest of Asia Pacific
8.5 Middle East & Africa
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 Saudi Arabia
8.5.4 South Africa
8.5.5 Rest of MEA
8.6 South America
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 Brazil
8.6.3 Argentina
8.6.4 Rest of South America
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPETITIVE SCENARIO
9.3 COMPANY MARKET RANKING ANALYSIS
10 COMPANY PROFILES
10.1 THERMO FISHER SCIENTIFIC
10.1.1 COMPANY OVERVIEW
10.1.2 COMPANY INSIGHTS
10.1.3 SEGMENT BREAKDOWN
10.1.4 PRODUCT BENCHMARKING
10.1.5 KEY DEVELOPMENTS
10.1.6 SWOT ANALYSIS
10.2 Bio-Techne
10.2.1 COMPANY OVERVIEW
10.2.2 COMPANY INSIGHTS
10.2.3 SEGMENT BREAKDOWN
10.2.4 PRODUCT BENCHMARKING
10.2.5 KEY DEVELOPMENTS
10.2.6 SWOT ANALYSIS
10.3 QIAGEN N.V
10.3.1 COMPANY OVERVIEW
10.3.2 COMPANY INSIGHTS
10.3.3 SEGMENT BREAKDOWN
10.3.4 PRODUCT BENCHMARKING
10.3.5 KEY DEVELOPMENTS
10.3.6 SWOT ANALYSIS
10.4 SYSTEM BIOSCIENCES
10.4.1 COMPANY OVERVIEW
10.4.2 COMPANY INSIGHTS
10.4.3 SEGMENT BREAKDOWN
10.4.4 PRODUCT BENCHMARKING
10.4.5 KEY DEVELOPMENTS
10.4.6 SWOT ANALYSIS
10.5 NX PHARMAGEN
10.5.1 COMPANY OVERVIEW
10.5.2 COMPANY INSIGHTS
10.5.3 SEGMENT BREAKDOWN
10.5.4 PRODUCT BENCHMARKING
10.5.5 SWOT ANALYSIS
10.6 AMS BIOTECHNOLOGY
10.6.1 COMPANY OVERVIEW
10.6.2 COMPANY INSIGHTS
10.6.3 SEGMENT BREAKDOWN
10.6.4 PRODUCT BENCHMARKING
10.6.5 KEY DEVELOPMENTS
10.7 NORGEN BIOTEK CORP
10.7.1 COMPANY OVERVIEW
10.7.2 COMPANY INSIGHTS
10.7.3 SEGMENT BREAKDOWN
10.7.4 PRODUCT BENCHMARKING
10.8 MILTENYI BIOTEC
10.8.1 COMPANY OVERVIEW
10.8.2 COMPANY INSIGHTS
10.8.3 PRODUCT BENCHMARKING
10.8.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved